(Boston)—Type 1 diabetes is a genetically-driven autoimmune disease of pancreatic beta-cells, whose origins remain unknown. Researchers at the Boston Medical Center (BMC) and Boston University School of Medicine (BUSM) ...
Jan 28, 2014
0
0
(Medical Xpress)—The autoimmune process leading to type 1 diabetes can develop quickly in some children and young people but very slowly in others despite the presence of proteins in their blood indicating an on-going autoimmune ...
Jan 9, 2014
0
0
(HealthDay)—Using a specially designed chamber, an international research team has transplanted islet cells into a patient with type 1 diabetes.
Oct 28, 2013
2
0
Joslin researchers have identified immune cells that promote growth of beta cells in type 1 diabetes. This study provides further evidence of a changed role for immune cells in type 1 diabetes pathology. The study appears ...
Sep 27, 2013
0
1
A drug formerly used to treat the skin disorder psoriasis has shown encouraging results in a phase 2 trial to assess its effectiveness in treating type 1 diabetes, according to new research published in The Lancet Diabetes ...
Sep 22, 2013
0
0
The immune system is normally known for protecting the body from illness. But a subset of immune cells appear to be doing more harm than good.
Sep 5, 2013
0
0
(Medical Xpress)—A large team with members from several research institutions across the U.S. has found a possible link between the expression of the gene for glycine amidinotransferase (GATM) and pain experienced by patients ...
Researchers at Lund University have unexpectedly discovered that an old cancer drug can be used to prevent rejection of transplanted tissue. The researchers now have high hopes that their discovery could lead to new treatments ...
Aug 29, 2013
0
0
(Medical Xpress)—A drug in clinical trials has been shown to preserve insulin-producing pancreatic beta cells in nearly half of subjects newly diagnosed with type 1 diabetes. Results of the phase 2 trials are published ...
Aug 6, 2013
0
0
Mature cells develop through a number of immature stages. During this process, they must remember the specialization they are committed to. For immune system B cells, Rudolf Grosschedl of the Max Planck Institute of Immunobiology ...
Jul 23, 2013
0
0
